Neurocognitive and sociodemographic functioning of glioblastoma long-term survivors

Journal of Neuro-Oncology

Volumn 109, Issue 2, 2012, Pages 331-339

  Flechl, Birgit ^a   Ackerl, Michael ^a   Sax, Cornelia ^a   Dieckmann, Karin ^a   Crevenna, Richard ^a   Gaiger, Alexander ^a   Widhalm, Georg ^a   Preusser, Matthias ^a   Marosi, Christine ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Brain tumor; Cognition; Glioblastma multiforme; Long term survivor; Neurocognitive outcome; Quality of life; Sociodemographic characteristics

Indexed keywords

DACARBAZINE; FOTEMUSTINE; TEMOZOLOMIDE;

ACTIVITIES OF DAILY LIVING FORM; ADULT; AGED; ANXIETY; ARTICLE; BARTHEL INDEX; BOSTON APHASIA SEVERITY SCALE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVOR; CLINICAL ARTICLE; COGNITION; DAILY LIFE ACTIVITY; DEMOGRAPHY; DEPRESSION; DISABILITY; DROWSINESS; EORTC QUALITY OF LIFE QUESTIONNAIRE BRAIN CANCER MODULE; EORTC QUALITY OF LIFE QUESTIONNAIRE C30; FATIGUE; FEMALE; GLIOBLASTOMA; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INSTRUMENTAL ACTIVITIES OF DAILY LIVING FORM; MALE; MOTOR DYSFUNCTION; MULTIPLE CYCLE TREATMENT; NEUROCOG FX TEST; NEUROLOGIC EXAMINATION; NINE HOLE PEG TEST; PSYCHOLOGICAL RATING SCALE; QUALITY OF LIFE; SCORING SYSTEM; SOCIAL INTERACTION; TEN METER WALKING TEST;

ADULT; AGED; ANXIETY; COGNITION DISORDERS; DEPRESSION; DISABLED PERSONS; FEMALE; GLIOBLASTOMA; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOVEMENT DISORDERS; NEUROPSYCHOLOGICAL TESTS; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; SURVIVORS; YOUNG ADULT;

EID: 84866010203     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-012-0897-1     Document Type: Article

References (38)

1. Das P, Puri T, Jha P et al (2011) A clinicopathological and molecular analysis of glioblastoma multiforme with long-term survival. J Clin Neurosci 18:66-70
2. Deb P, Sharma MC, Mahapatra AK et al (2005) Glioblastoma multiforme with long term survival. Neurol India 53:329-332 (Pubitemid 41526848)
3. Scott JN, Rewcastle NB, Brasher PM et al (1999) Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol 46:183-188 (Pubitemid 29382874)
4. Yukihiko S, Toshihiro K, Mika W et al (2009) Long-term survivors of glioblastoma: clinical features and molecular analysis. Acta Neurochir (Wien) 151:1349-1358
5. Preusser M, de Ribaupierre S, Wöhrer A, Erridge SC, Hegi M, Weller M, Stupp R (2011) Current concepts and management of glioblastoma. Ann Neurol 70:9-21
6. Beauchesne P, Bernier V, Carnin C et al (2010) Prolonged survival for patients with newly diagnosed, inoperable glioblastoma with 3-times daily ultrafractionated radiation therapy. Neuro Oncol 12:595-602
7. Stupp R, Hegi ME, Mason WP et al (2009) European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group: Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study:5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459-466
8. Wöhrer A, Waldhör T, Heinzl H et al (2009) The Austrian Brain Tumour Registry: a cooperative way to establish a populationbased brain tumour registry. J Neurooncol 95:401-411
9. Pelletier G, Verhoef MJ, Khatri N et al (2002) Quality of life in brain tumor patients: The relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol 57:41-49 (Pubitemid 34692613)
10. Hilverda K, Bosma I, Heimans JJ et al (2010) Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: initial findings. J Neurooncol 97:89-94
11. Mukand JA, Blackinton DD, Crincoli MG et al (2001) Incidence of neurologic deficits and rehabilitation of patients with brain tumors. Am J Phys Med Rehabil 80:346-350 (Pubitemid 32378119)
12. Taphoorn MJ, van den Bent MJ, Mauer ME et al (2007) European Organisation for Research and Treatment of Cancer: healthrelated quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer Randomized Clinical Trial. J Clin Oncol 25:5723-5730
13. Taphoorn MJ, Klein M (2004) Cognitive deficits in adult patients with brain tumours. Lancet Neurol 3:159-168 (Pubitemid 38229950)
14. Wefel JS, Cloughesy T, Zazzali JL et al (2011) Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab. Neuro Oncol 13:660-668
15. Hottinger AF, Yoon H, DeAngelis LM et al (2009) Neurological outcome of long-term glioblastoma survivors. J Neurooncol 95:301-305
16. Fazeny-Dörner B, Gyries A, Rössler K et al (2003) Survival improvement in patients with glioblastoma multiforme during the last 20 years in a single tertiary-care center. Wien Klin Wochenschr 115:389-397 (Pubitemid 36827700)
17. Hoppe C, Fliessbach K, Schlegel U et al (2009) NeuroCog FX: computerized screening of cognitive functions in patients with epilepsy. Epilepsy Behav 16:298-310
18. Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organisation for Research and Treatment of Cancer QLQC30. A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376 (Pubitemid 23073154)
19. Bottomley A, Vanvoorden V, Flechtner H et al (2003) The challenge and achievements of implementation of quality of life research in cancer clinical trials. Eur J Cancer 39:275-285 (Pubitemid 36140042)
20. Taphoorn MJ, Claassens L, Aaronson NK et al (2010) EORTC Quality of Life Group, and Brain Cancer, NCIC and Radiotherapy Groups: an international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Eur J Cancer 46:1033-1040
21. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361-370 (Pubitemid 13098606)
22. Herrmann C (1997) International experiences with the hospital anxiety and depression scale-a review of validation data and clinical results. J Psychosom Res 42:17-41 (Pubitemid 27095712)
23. Grant R, Slattery J, Gregor A et al (1994) Recording neurological impairment in clinical trials of glioma. J Neurooncol 19:37-49 (Pubitemid 24258539)
24. Boston Diagnostic Examination Booklet. Les and Febiger, Philadelphia
25. Clyde Z, Chataway SJ, Signorini D et al (1998) Significant change in tests of neurological impairment in patients with brain tumors. J Neurooncol 39:81-90 (Pubitemid 28430111)
26. Schwarz R, Hinz A (2001) Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eu J Cancer 37:1345-1351 (Pubitemid 32588744)
27. Taphoorn MJ, Sizoo EM, Bottomley A (2010) Review on quality of life issues in patients with primary brain tumors. Oncologist 15:618-626
28. Hassler MR, Elandt K, Preusser M et al (2010) Neurocognitive training in patients with high-grade glioma: a pilot study. J Neurooncol 97:109-115
29. Scoccianti S, Magrini SM, Ricardi U et al (2010) Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: a multicenter study by the Central Nervous System Study Group of Airo (Italian Association of Radiation Oncology). Neurosurgery 67:446-458
30. Poelen J, Prick MJ, Jeuken JW et al (2009) Six year survival after prolonged temozolomide treatment in a 30-year-old patient with glioblastoma. Acta Neurol Belg 109:238-242
31. Herman MA, Tremont-Lukats I, Meyers CA et al (2003) Neurocognitive and functional assessment of patients with brain metastases: a pilot study. Am J Clin Oncol 26:273-279 (Pubitemid 36712643)
32. Ek L, Almkvist O, Wiberg MK et al (2010) Early cognitive impairment in a subset of patients with presumed low-grade glioma. Neurocase 16:503-511
33. Jalali R, Mallick I, Dutta D et al (2010) Factors influencing neurocognitive outcomes in young patients with benign and lowgrade brain tumors treated with stereotactic conformal radiotherapy. Int J Radiat Oncol Biol Phys 77:974-979
34. Sheline GE, Wara WM, Smith V (1980) Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 6:1215-1228 (Pubitemid 10016476)
35. Crossen JR, Garwood D, Glatstein E et al (1994) Neurobehavioral sequelae of cranial irradiation in adults: a review of radiationinduced encephalopathy. J Clin Oncol 12:627-642 (Pubitemid 24079908)
36. Armstrong CL, Gyato K, Awadalla AW et al (2004) A critical review of the clinical effects of therapeutic irradiation damage to the brain: the roots of controversy. Neuropsychol Rev 14:65-86 (Pubitemid 39023957)
37. Schmidinger M, Linzmayer L, Becherer A et al (2003) Psychometricand quality-of-life assessment in long-term glioblastoma survivors. J Neurooncol 63:55-61 (Pubitemid 36681643)
38. Steinbach JP, Blaicher HP, Herrlinger U et al (2006) Surviving glioblastoma for more than 5 years: the patient's perspective. Neurology 66:239-242 (Pubitemid 43970162)